Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway

Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway

(2017) Shanshan S Wang et al.   Cell Death & Disease

Cholangiocarcinoma — Current Treatment Options

(2017) S. Friman   Scandinavian Journal of Surgery

Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells

(2016) Xiaofang Zhao et al.   Oncotarget

Autophagy and p53

(2016) Eileen White   Cold Spring Harbor Perspectives in Medicine

PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression

(2015) Tao Luo et al.   Autophagy

The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma

(2015) Matthew Howell et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

The Combination of Rapamycin and Resveratrol Blocks Autophagy and Induces Apoptosis in Breast Cancer Cells

(2015) Anya Alayev et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Autophagic cell death unraveled: Pharmacological inhibition of apoptosis and autophagy enables necrosis

(2014) Eileen White   Autophagy

The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration

(2014) David Heras-Sandoval et al.   CELLULAR SIGNALLING

Molecular pathogenesis of intrahepatic cholangiocarcinoma

(2014) Jesper B. Andersen   Journal of Hepato-Biliary-Pancreatic Sciences

JNK Contributes to the Tumorigenic Potential of Human Cholangiocarcinoma Cells through the mTOR Pathway Regulated GRP78 Induction

(2014) Chunhong Feng et al.   PLoS One

Implication of transcriptional repression in compound C-induced apoptosis in cancer cells

(2013) R Y Dai et al.   Cell Death & Disease

Effect of the AMP-Kinase Modulators AICAR, Metformin and Compound C on Insulin Secretion of INS-1E Rat Insulinoma Cells under Standard Cell Culture Conditions

(2012) Christian Langelueddecke et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

The Tyrosine Kinase c-Met Contributes to the Pro-tumorigenic Function of the p38 Kinase in Human Bile Duct Cholangiocarcinoma Cells

(2012) Rongyang Dai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

c-Met function requires n-linked glycosylation modification of pro-Met

(2012) Run Chen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells

(2012) Weng-Lang Yang et al.   JOURNAL OF SURGICAL ONCOLOGY

p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells

(2012) Shi-Wei Huang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

p53 signaling and autophagy in cancer: A revolutionary strategy could be developed for cancer treatment

(2011) Xinbing Sui et al.   Autophagy

Akt, FoxO and regulation of apoptosis

(2011) Xinbo Zhang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

(2011) Maria M. Mihaylova et al.   NATURE CELL BIOLOGY

Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway

(2010) Ljubica Vucicevic et al.   Autophagy

Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis

(2010) Chengyin Min et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Epidemiology of cholangiocarcinoma: An update focusing on risk factors

(2009) Hai-Rim Shin et al.   CANCER SCIENCE

AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells

(2009) Junfei Jin et al.   JOURNAL OF LIPID RESEARCH

AMP-activated protein kinase promotes human prostate cancer cell growth and survival

(2009) H. U. Park et al.   MOLECULAR CANCER THERAPEUTICS

Does autophagy have a license to kill mammalian cells?

(2008) F Scarlatti et al.   CELL DEATH AND DIFFERENTIATION

c-Met targeted therapy of cholangiocarcinoma

(2008) Matei P Socoteanu et al.   WORLD JOURNAL OF GASTROENTEROLOGY